Your browser doesn't support javascript.
loading
Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study.
Kersten, Marie José; Driessen, Julia; Zijlstra, Josée M; Plattel, Wouter J; Morschhauser, Franck; Lugtenburg, Pieternella J; Brice, Pauline; Hutchings, Martin; Gastinne, Thomas; Liu, Roberto; Burggraaff, Coreline N; Nijland, Marcel; Tonino, Sanne H; Arens, Anne I J; Valkema, Roelf; van Tinteren, Harm; Lopez-Yurda, Marta; Diepstra, Arjan; De Jong, Daphne; Hagenbeek, Anton.
Afiliação
  • Kersten MJ; Dept of Hematology, Amsterdam UMC, University of Amsterdam, and LYMMCARE, Amsterdam, The Netherlands.
  • Driessen J; Dept of Hematology, Amsterdam UMC, University of Amsterdam, and LYMMCARE, Amsterdam, The Netherlands.
  • Zijlstra JM; Dept of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Plattel WJ; Dept of Hematology, University of Groningen, UMC Groningen, Groningen, The Netherlands.
  • Morschhauser F; Dept of Hematology, Centre Hospitalier Universitaire, Lille, France.
  • Lugtenburg PJ; Dept of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Brice P; Dept of Hematology, Hopital Saint Louis, Paris, France.
  • Hutchings M; Dept of Hematology, Rigshospitalet, Copenhagen, Denmark.
  • Gastinne T; Dept of Hematology, Centre Hospitalier Universitaire, Nantes, France.
  • Liu R; Dept of Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Burggraaff CN; Dept of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Nijland M; Dept of Hematology, University of Groningen, UMC Groningen, Groningen, The Netherlands.
  • Tonino SH; Dept of Hematology, Amsterdam UMC, University of Amsterdam, and LYMMCARE, Amsterdam, The Netherlands.
  • Arens AIJ; Dept of Radiology and Nuclear Medicine, Radboud university medical center, Nijmegen, The Netherlands.
  • Valkema R; Dept of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands.
  • van Tinteren H; Dept of Biometrics, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Lopez-Yurda M; Dept of Biometrics, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Diepstra A; Dept. of Pathology and Medical Biology, UMC Groningen, University of Groningen, the Netherlands.
  • De Jong D; Dept of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Hagenbeek A; Dept of Hematology, Amsterdam UMC, University of Amsterdam, and LYMMCARE, Amsterdam, The Netherlands.
Haematologica ; 106(4): 1129-1137, 2021 04 01.
Article em En | MEDLINE | ID: mdl-32273476
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article